These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
229 related items for PubMed ID: 6887774
21. [When thinking to scleroderma?]. Cogan E. Rev Med Brux; 2007 Sep; 28(4):285-9. PubMed ID: 17958022 [Abstract] [Full Text] [Related]
23. A growing need for capillaroscopy in rheumatology. De Angelis R, Grassi W, Cutolo M. Arthritis Rheum; 2009 Mar 15; 61(3):405-10. PubMed ID: 19248132 [No Abstract] [Full Text] [Related]
24. [General practice-relevant diagnostic and differential diagnostic aspects of collagen diseases. Sclerodermia progressiva, dermatomyositis and periarteritis nodosa]. Apostoloff E, Sönnichsen N. Z Arztl Fortbild (Jena); 1987 Mar 15; 81(8):388-91. PubMed ID: 2887075 [No Abstract] [Full Text] [Related]
25. [Scleroderma and Raynaud's phenomenon: current pathogenetic interpretations and clinico-therapeutic trends]. Zelli GP, Cannata P. Ann Ital Chir; 1981 Mar 15; 53(3):337-43. PubMed ID: 7337317 [No Abstract] [Full Text] [Related]
26. The spectrum of scleroderma. LeRoy EC, Lomeo R. Hosp Pract (Off Ed); 1989 Oct 30; 24(10A):33-42 contd. PubMed ID: 2509491 [No Abstract] [Full Text] [Related]
27. [Clinical significance of antimitotic spindle-associated antibody assay]. Obayashi H, Wada T, Fukui I, Nakayama A. Nihon Rinsho; 1990 Feb 30; 48 Suppl():599-602. PubMed ID: 2192157 [No Abstract] [Full Text] [Related]
28. [Anticentromere antibodies and lung disease without skin involvement]. Fernández-Fernández FJ, Sesma P, Facio A, Guerra JL, González-Moraleja J. An Med Interna; 1997 Apr 30; 14(4):196-8. PubMed ID: 9181818 [Abstract] [Full Text] [Related]
30. Unilateral limited scleroderma-like changes following formation of an arteriovenous fistula. Roberts H, Curnow PA. Australas J Dermatol; 2007 Feb 01; 48(1):37-9. PubMed ID: 17222301 [Abstract] [Full Text] [Related]
31. Low plasma protein nitrotyrosine levels distinguish primary Raynaud's phenomenon from scleroderma. Kingdon EJ, Mani AR, Frost MT, Denton CP, Powis SH, Black CM, Moore KP. Ann Rheum Dis; 2006 Jul 01; 65(7):952-4. PubMed ID: 16308344 [Abstract] [Full Text] [Related]
32. [Raynaud's syndrome and scleroderma. I. Scleroderma-like changes in Raynaud's syndrome and their differentiation from scleroderma]. JABLONSKA S, LUKASIAK B, BUBNOW B. Pol Tyg Lek (Wars); 1957 Sep 23; 12(39):1481-6. PubMed ID: 13505250 [No Abstract] [Full Text] [Related]
33. [The CREST syndrome. Apropos of a case]. Nogueira J, Sayago M, Márquez JL, Caballero J, Muñoz E, Trujillo L, de la Santa J. Rev Esp Enferm Apar Dig; 1986 Oct 23; 70(4):355-9. PubMed ID: 3786917 [No Abstract] [Full Text] [Related]
35. Lack of correlation between gastric Helicobacter pylori infection and primary or secondary Raynaud's phenomenon in patients with systemic sclerosis. Sulli A, Seriolo B, Savarino V, Cutolo M. J Rheumatol; 2000 Jul 23; 27(7):1820-1. PubMed ID: 10914880 [No Abstract] [Full Text] [Related]
36. [Scleroderma and porphyria cutanea tarda with clinical manifestations of scleroderma]. Kochetov DP, Krivosheev BN. Vestn Dermatol Venerol; 1976 Jan 23; (1):64-8. PubMed ID: 997866 [No Abstract] [Full Text] [Related]
37. [CRST syndrome--a type of progressive systemic sclerosis]. Jurkas L. Lakartidningen; 1989 Nov 22; 86(47):4109-10. PubMed ID: 2593741 [No Abstract] [Full Text] [Related]
38. The prognostic value of nailfold capillary changes for the development of connective tissue disease in children and adolescents with primary raynaud phenomenon: a follow-up study of 250 patients. Pavlov-Dolijanović S, Damjanov N, Ostojić P, Susić G, Stojanović R, Gacić D, Grdinić A. Pediatr Dermatol; 2006 Nov 22; 23(5):437-42. PubMed ID: 17014637 [Abstract] [Full Text] [Related]
39. [Case demonstration: CRST-syndrome]. Loth H. Z Hautkr; 1974 Jul 01; 49(13):583. PubMed ID: 4419029 [No Abstract] [Full Text] [Related]